Webcasts Event RSS
Upcoming Events Past Events
Cowen and Company's 40th Annual Health Care Conference
March 4, 2020
View the live Webcast
Halozyme To Host Fourth Quarter And Full Year 2019 Financial Results Webcast And Conference Call
February 24, 2020
View the live Webcast
38th Annual J.P. Morgan Healthcare Conference
January 16, 2020
View the live Webcast

Investor Materials

Thumb Date Download
July 20, 2018 Corporate Presentation 587 KB
January 1, 2018 2018 Annual Report 939 KB
December 31, 2017 2017 Annual Report 3.18 MB
July 24, 2016 2016 Annual Report 4.75 MB
July 23, 2016 2015 Annual Report 5.24 MB
July 21, 2016 2014 Annual Report 2.13 MB

Recent News

Date Title Press Release RSS
Halozyme Therapeutics To Present At The Cowen 40th Annual Health Care Conference 02/26/20
Halozyme Announces FDA Has Accepted Biologics License Application For Fixed-Dose Subcutaneous Combination Of Perjeta® And Herceptin® Using Enhanze® Technology 02/25/20
Halozyme Reports Fourth Quarter and Full Year 2019 Results 02/24/20
Halozyme Announces CFO Transition 02/24/20
See More

Investor Contacts

Al Kildani
Vice President, Investor Relations
& Corporate Communications
Phone: 858-704-8122
Email: akildani@halozyme.com
media@halozyme.com
ir@halozyme.com

Useful Links

Contact Info


Office:

Halozyme
11388 Sorrento Valley Road
San Diego, CA 92121
Phone: 858.794.8889
info@halozyme.com

Recent News

February 26, 2020 Halozyme Therapeutics To Present At The Cowen 40th Annual Health Care Conference
February 25, 2020 Halozyme Announces FDA Has Accepted Biologics License Application For Fixed-Dose Subcutaneous Combination Of Perjeta® And Herceptin® Using Enhanze® Technology
February 24, 2020 Halozyme Reports Fourth Quarter and Full Year 2019 Results
Copyright© 2015-2019. Halozyme, Inc. All rights reserved. All trademarks belong to their respective owners.
Powered By Q4 Inc. 5.30.0.2

Notice

You are now leaving Halozyme.com. Halozyme is not responsible for or endorses the content of the linked site.

Ok